Pricing

Asceneuron

0 followers

‌

Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease.

Industries

Biotechnology, Health Care

Headquarters

Lausanne, Switzerland

Employees

11-50

Links

Org chart

Barbara Angehrn Pavik

Chief Executive Officer

Barbara Angehrn Pavik

Collapse

Sandra Millet

Head Of Operations

Matthew Foy

Investor

Eric Yuen

Scientific Advisory Board Member

Andrin Cerletti

Head Of Business Development

Abbas Hussain

Chairman

Henrijette Richter

Board Member

Ruhi Ahmed

SVP & Head of Regulatory Affairs

Bruno Permanne

Senior Director & Head of Preclinical Development

Colin Kahrs

Head of Intellectual Property

Teams

Scientific and Clinical Development

9 members

Leadership Team

2 members

Offices

Similar companies

Lonza

37 followers

Nestlé Health Science

27 followers

Verdiva Bio

1 follower

Roche

283 followers

Synthekine

3 followers

Kyverna Therapeutics

7 followers

Caribou Biosciences

2 followers

Vera Therapeutics

2 followers

Neogene Therapeutics

2 followers

Merck

230 followers

Generate Biomedicines

3 followers

Explore companies